Switch theme
Sign up to access all valuation multiples
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
1996
2.5K+
LTM Revenue $678M
LTM EBITDA $91.6M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Med Life has a last 12-month revenue (LTM) of $678M and a last 12-month EBITDA of $91.6M.
In the most recent fiscal year, Med Life achieved revenue of $633M and an EBITDA of $90.3M.
Med Life expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Med Life valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $678M | XXX | $633M | XXX | XXX | XXX |
| Gross Profit | $562M | XXX | $516M | XXX | XXX | XXX |
| Gross Margin | 83% | XXX | 82% | XXX | XXX | XXX |
| EBITDA | $91.6M | XXX | $90.3M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $38.6M | XXX | $35.3M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $9.9M | XXX | $6.0M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $290M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 4, 2025, Med Life's stock price is RON 7 (or $2).
Med Life has current market cap of RON 3.6B (or $830M), and EV of RON 5.2B (or $1.2B).
See Med Life trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $830M | XXX | XXX | XXX | XXX | $0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 4, 2025, Med Life has market cap of $830M and EV of $1.2B.
Med Life's trades at 1.9x EV/Revenue multiple, and 13.5x EV/EBITDA.
Equity research analysts estimate Med Life's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Med Life has a P/E ratio of 83.8x.
See valuation multiples for Med Life and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $830M | XXX | $830M | XXX | XXX | XXX |
| EV (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.3x | XXX | 13.5x | XXX | XXX | XXX |
| EV/EBIT | 31.6x | XXX | 34.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 83.8x | XXX | 139.5x | XXX | XXX | XXX |
| EV/FCF | -224.0x | XXX | 186.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMed Life's last 12 month revenue growth is 12%
Med Life's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Med Life's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Med Life's rule of X is 44% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Med Life and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | 26% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 76% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Med Life acquired XXX companies to date.
Last acquisition by Med Life was XXXXXXXX, XXXXX XXXXX XXXXXX . Med Life acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Med Life founded? | Med Life was founded in 1996. |
| Where is Med Life headquartered? | Med Life is headquartered in Romania. |
| How many employees does Med Life have? | As of today, Med Life has 2.5K+ employees. |
| Who is the CEO of Med Life? | Med Life's CEO is Mr. Mihail Marcu. |
| Is Med Life publicy listed? | Yes, Med Life is a public company listed on BSE. |
| What is the stock symbol of Med Life? | Med Life trades under M ticker. |
| When did Med Life go public? | Med Life went public in 2016. |
| Who are competitors of Med Life? | Similar companies to Med Life include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Med Life? | Med Life's current market cap is $830M |
| What is the current revenue of Med Life? | Med Life's last 12 months revenue is $678M. |
| What is the current revenue growth of Med Life? | Med Life revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Med Life? | Current revenue multiple of Med Life is 1.8x. |
| Is Med Life profitable? | Yes, Med Life is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Med Life? | Med Life's last 12 months EBITDA is $91.6M. |
| What is Med Life's EBITDA margin? | Med Life's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Med Life? | Current EBITDA multiple of Med Life is 13.3x. |
| What is the current FCF of Med Life? | Med Life's last 12 months FCF is -$5.5M. |
| What is Med Life's FCF margin? | Med Life's last 12 months FCF margin is -1%. |
| What is the current EV/FCF multiple of Med Life? | Current FCF multiple of Med Life is -224.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
